Finch Therapeutics Group, Inc.
FNCH
$13.25
-$0.20-1.49%
| 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | 06/30/2023 | |
|---|---|---|---|---|---|
| Net Income | -4.83M | -3.88M | -3.04M | -2.42M | -6.95M |
| Total Depreciation and Amortization | 44.00K | 43.00K | 44.00K | 52.00K | 57.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 592.00K | 594.00K | 77.00K | 1.08M | -292.00K |
| Change in Net Operating Assets | -528.00K | -1.12M | -786.00K | -3.97M | -1.97M |
| Cash from Operations | -4.73M | -4.36M | -3.71M | -5.26M | -9.16M |
| Capital Expenditure | -- | -- | 14.00K | 0.00 | 0.00 |
| Sale of Property, Plant, and Equipment | -- | -- | 37.00K | 20.00K | 1.27M |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | 51.00K | 20.00K | 1.27M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | 0.00 | 0.00 | 0.00 |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | 0.00 | 0.00 | 4.00K |
| Cash from Financing | -- | -- | 0.00 | 0.00 | 4.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -4.73M | -4.36M | -3.66M | -5.24M | -7.88M |
